Mometasone Furoate Anhydrous (API – CAS 83919-23-7)

Mometasone Furoate Anhydrous, CAS 83919-23-7, is a bulk pharmaceutical-grade API in the corticosteroid therapeutic category. Sourced from India, it is available for export to key markets including EU, USA, Brazil, China, South Korea, Taiwan, Middle East.

Category:

Request a Quote

Mometasone Furoate Anhydrous · CAS 83919-23-7 · Corticosteroid

Overview

Mometasone Furoate Anhydrous is a potent corticosteroid active pharmaceutical ingredient (API) in the Corticosteroid therapeutic category. It is widely used in topical, ophthalmic, oral, and parenteral formulations for its anti-inflammatory and immunosuppressive properties. Manufactured to IP / BP / USP / EP pharmacopoeial standards.

Therapeutic Application

Mometasone Furoate is a potent corticosteroid used in topical formulations for inflammatory skin conditions, in nasal sprays for allergic rhinitis, and in inhalation therapy for asthma.

Specifications

  • CAS Number: 83919-23-7
  • Appearance: White to off-white crystalline powder
  • Typical Assay/Purity: ≥ 99.0%
  • Common Pharmacopeial Grades: IP / BP / USP / EP
  • Storage: Store in a cool, dry place, away from light
  • Shelf Life: Typically 24 months under recommended storage conditions

Regulatory & Compliance

Intravarsity adheres to WHO-GMP manufacturing practices, ensuring that Mometasone Furoate Anhydrous is produced in compliance with international quality standards. DMF Status: CEP No. R1-CEP 2008-221-Rev 03. Approved regulatory authorities/registrations: ANVISA, KFDA, CDE-NMPA, EU GMP, TFDA. Availability of regulatory documents such as USDMF, CEP, and EU-GMP certificates, along with Certificates of Analysis (COA) and Certificates of Suitability (COS), is subject to inquiry.

Packaging & Shipping

Mometasone Furoate Anhydrous is packaged in 25kg HDPE drums with double LDPE liners, palletized for secure transport. All necessary export documentation is provided, facilitating shipping to key markets including EU, USA, Brazil, China, South Korea, Taiwan, Middle East.

Common Use Cases & Finished Dosage Forms

This API is typically incorporated into various dosage forms including:

  • Tablets
  • Capsules
  • Injectable solutions

Ordering Information

The minimum order quantity (MOQ) for Mometasone Furoate Anhydrous is subject to inquiry. Interested parties are encouraged to request a Certificate of Analysis (COA) and a quote via this listing. For further inquiries, please contact Intravarsity directly.

Reviews

There are no reviews yet.

Be the first to review “Mometasone Furoate Anhydrous (API – CAS 83919-23-7)”

Your email address will not be published. Required fields are marked *